Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer

Affiliations

¹ Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. Electronic address: Kevin.Harrington@icr.ac.uk.
² Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
³ University College London Hospital, London, UK.
⁴ Queen Elizabeth Hospital, Birmingham, UK.
⁵ King's College, London, UK.
⁶ Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
⁷ Leeds Cancer Centre, St James's Hospital, Leeds, UK.
⁸ The Clatterbridge Cancer Centre, Liverpool, UK; The University of Liverpool, Liverpool, UK.
⁹ Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.

Editorial

K J Harrington et al. Clin Oncol (R Coll Radiol). 2020 Aug.

. 2020 Aug;32(8):490-492.

doi: 10.1016/j.clon.2020.05.016. Epub 2020 Jun 6.

¹ Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. Electronic address: Kevin.Harrington@icr.ac.uk.
² Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
³ University College London Hospital, London, UK.
⁴ Queen Elizabeth Hospital, Birmingham, UK.
⁵ King's College, London, UK.
⁶ Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
⁷ Leeds Cancer Centre, St James's Hospital, Leeds, UK.
⁸ The Clatterbridge Cancer Centre, Liverpool, UK; The University of Liverpool, Liverpool, UK.
⁹ Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.

No abstract available

References

1. https://www.nice.org.uk/guidance/ng161/chapter/6-Prioritising-systemic-a...
1. https://www.nice.org.uk/guidance/ng161/resources/interim-treatment-chang...
1. Liang W., Guan W., Chen R., Wang W., Li J., Xu K. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337. - PMC - PubMed
1. Zhang L., Zhu F., Xie L., Wang C., Wang J., Chen R. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020:36383–36393. pii: S0923-7534(20) - PMC - PubMed
1. Yu J., Ouyang W., Chua M.L.K., Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020 doi: 10.1001/jamaoncol.2020.0980. - DOI - PMC - PubMed